According the to Erwann Loret, searcher of the CNRS.

This treatment doesn't totally cure the virus, but with the T lymphocites, the body will stop to fight itself.

More informations : Publication in Retrovirology of the results of Biosantech's phase IIA clinical trial for the anti-HIV candidate vaccine | Business Wire
Vaccin contre le Sida : une avancée qui demande confirmation -